AIIMS Delhi to Start Screening Children Aged 6-12 Years for COVID-19 Vaccine Covaxin Trials from Tomorrow Onwards: Sources
After the recruitment of 6-12 year old children AIIMS Delhi will be conducting trials for the age group 2-6 yr old. The trails are taking place at 525 centres. AIIMS Patna, Mysore Medical College and Reaserch Institute in Karnataka have also been selected to conduct clinical trials on children.
New Delhi, June 14: The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin is scheduled to start from Tuesday. According to sources, the recruitment for clinical trials of Covaxin among those aged 12 to 18 years is over. They have been given a single dose of vaccine.
After the recruitment of 6-12 yr old children AIIMS Delhi will be conducting trials for the age group 2-6 yr old. The trails are taking place at 525 centres.
AIIMS Patna, Mysore Medical College and Reaserch Institute in Karnataka have also been selected to conduct clinical trials on children. Single Dose of COVID-19 Vaccine Is Sufficient for Those Already Infected by Coronavirus, Says Study.
"We have started recruitment for children aged 6-12 years. Recruitments for clinical trails on children aged 12-18 years is over. They will be kept under observation." said Prabhat Kumar Singh, Director, AIIMS, Patna.
(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)